Publication Name	World Journal of Hepatology
Manuscript ID	13552
Country	France

Received	2014-08-27 08:22
Peer-Review Started	2014-08-28 08:44
To Make the First Decision	2014-09-16 10:53
Return for Revision	2014-09-19 17:27
Revised	2014-10-02 13:48
Second Decision	2014-11-21 08:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-12-01 14:07
Articles in Press	2014-12-01 14:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-20 12:16
Publish the Manuscript Online	2015-03-31 15:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
Manuscript Source	Invited Manuscript
All Author List	Xavier Adhoute, Guillaume Penaranda, Paul Castellani, Herve Perrier and Marc Bourliere
Funding Agency and Grant Number
Corresponding Author	Dr. Xavier Adhoute, Department of Hepatology, Hopital Saint-Joseph, 26 boulevard Louvain, 13285 Marseille, France. adhoute.xavier@neuf.fr
Key Words	Hepatocellular carcinoma; Transarterial chemoembolization; Barcelona Clinic Liver Cancer; Prognostic scoring systems
Core Tip	Despite its widespread use in hepatocellular carcinoma, the indications for Transarterial chemoem-bolization are still debated. There are no rules about the treatment modalities or strategy to follow. To overcome these difficulties, a simple scoring system, including prognostic variables, designed as a decision support, would be useful. Deciding when we have to move from a loco-regional treatment to a systemic option is matter of significant interest, particularly since sorafenib now provides us with a solution.
Publish Date	2015-03-31 15:58
Citation	Adhoute X, Penaranda G, Castellani P, Perrier H, Bourliere M. Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system? World J Hepatol 2015; 7(3): 521-531
URL	http://www.wjgnet.com/1948-5182/full/v7/i3/521.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i3.521

Full Article (PDF)	WJH-7-521.pdf
Full Article (Word)	WJH-7-521.doc
Manuscript File	13552-Review.docx
Answering Reviewers	13552-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13552-Conflict of interest.pdf
Copyright License Agreement	13552-Copyright assignment.PDF
Peer-review Report	13552-Peer review(s).pdf
Scientific Misconduct Check	13552-CrossCheck.jpg
Scientific Editor Work List	13552-Scientific editor work list.pdf